We validated four gene fusions by PCR amplification of the predicted breakpoint junction from tumour cDNA: COL4A1‐VEGFD, SRF‐ICA1L, SRF‐CITED1 and MTCH2‐FNBP4 (Figure 1A and Figure S1). This evidence concerns the gene COL4A1 and neoplasm.